Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term ox… Read more
Inogen Inc (INGN) - Total Assets
Latest total assets as of September 2025: $307.01 Million USD
Based on the latest financial reports, Inogen Inc (INGN) holds total assets worth $307.01 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Inogen Inc - Total Assets Trend (2011–2024)
This chart illustrates how Inogen Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Inogen Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Inogen Inc's total assets of $307.01 Million consist of 62.6% current assets and 37.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 38.4% |
| Accounts Receivable | $30.10 Million | 10.2% |
| Inventory | $24.81 Million | 8.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $30.49 Million | 10.3% |
| Goodwill | $9.46 Million | 3.2% |
Asset Composition Trend (2011–2024)
This chart illustrates how Inogen Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Inogen Inc's current assets represent 62.6% of total assets in 2024, an increase from 43.3% in 2011.
- Cash Position: Cash and equivalents constituted 38.4% of total assets in 2024, up from 16.2% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 3.0% in 2011.
- Asset Diversification: The largest asset category is intangible assets at 10.3% of total assets.
Inogen Inc Competitors by Total Assets
Key competitors of Inogen Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Inogen Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Inogen Inc generates 1.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Inogen Inc is currently not profitable relative to its asset base.
Inogen Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.14 | 2.66 | 5.39 |
| Quick Ratio | 2.75 | 2.34 | 4.95 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $138.77 Million | $ 120.16 Million | $ 248.99 Million |
Inogen Inc - Advanced Valuation Insights
This section examines the relationship between Inogen Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.79 |
| Latest Market Cap to Assets Ratio | 0.50 |
| Asset Growth Rate (YoY) | -9.2% |
| Total Assets | $296.19 Million |
| Market Capitalization | $149.17 Million USD |
Valuation Analysis
Below Book Valuation: The market values Inogen Inc's assets below their book value (0.50 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Inogen Inc's assets decreased by 9.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Inogen Inc (2011–2024)
The table below shows the annual total assets of Inogen Inc from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $296.19 Million | -9.20% |
| 2023-12-31 | $326.19 Million | -19.47% |
| 2022-12-31 | $405.04 Million | -17.26% |
| 2021-12-31 | $489.51 Million | +5.99% |
| 2020-12-31 | $461.85 Million | +3.24% |
| 2019-12-31 | $447.34 Million | +19.01% |
| 2018-12-31 | $375.90 Million | +36.65% |
| 2017-12-31 | $275.07 Million | +28.51% |
| 2016-12-31 | $214.05 Million | +32.69% |
| 2015-12-31 | $161.31 Million | +15.15% |
| 2014-12-31 | $140.09 Million | +70.01% |
| 2013-12-31 | $82.40 Million | +73.15% |
| 2012-12-31 | $47.59 Million | +97.20% |
| 2011-12-31 | $24.13 Million | -- |